HBV confers innate immune evasion through triggering HAT1/acetylation of H4K5/H4K12/miR-181a-5p or KPNA2/cGAS-STING/IFN-I signaling.
Zhao L, Yuan H, Wang Y, Geng Y, Yun H, Zheng W, Yuan Y, Lv P, Hou C, Zhang H, Sun J, Sun L, Suo Y, Wang S, Zhang N, Lu W, Yang G, Zhang X.
Zhao L, et al. Among authors: zheng w.
J Med Virol. 2023 Jul;95(7):e28966. doi: 10.1002/jmv.28966.
J Med Virol. 2023.
PMID: 37466313